Evaluation of (1->3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis Pneumonia

Evaluation of (1->3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis Pneumonia - HIV-BG

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014818

Enrollment

180

Registered

2014-08-11

Start date

2014-08-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV associated Pneumocystis pneumonia (PCP)

Interventions

To measure BG.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. New HIV patients. 2. HIV patients who are diagnosed as PCP.

Exclusion criteria

Exclusion criteria: 1. Patients who do not consent to join this study. 2. Patients who cannot understand the explanation of this study because of impaired consciousness or mental problem. 3. Patients who are considered as inappropriate for this study by investigators.

Design outcomes

Primary

Measure	Time frame
To demonstrate the characteristics of BG as a diagnostic tool for HIV associated PCP.	—

Secondary

Measure	Time frame
To assess the influence of patient's background, HIV status (CD4 count, viral load), other concurrent opportunistic infections and complicating illnesses on the performance of BG.	—

Countries

Japan

Contacts

Public ContactTaiichiro Kobayashi

National Center for Global Health and Medicine AIDS Clinical Center

tkobayashi@cick.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Evaluation of (1-&gt;3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis Pneumonia